...
首页> 外文期刊>Journal of cellular biochemistry. >Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models
【24h】

Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models

机译:犬乳腺癌模型中改变的microRNA表达谱和INK4A / CDKN2A肿瘤抑制基因的调控。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

microRNA (miRNA) expression profiling of cancer versus normal cells may reveal the characteristic regulatory features that can be correlated to altered gene expression in both human and animal models of cancers. In this study, the comprehensive expression profiles of the 277 highly characterized miRNAs from the canine genome were evaluated in spontaneous canine mammary tumor (CMT) models harboring defects in a group of cell cycle regulatory and potent tumor suppressor genes of INK4/CDKN2 family including p16/INK4A, p14ARF, and p15/INK4B. A large number of differentially expressed miRNAs were identified in three CMT cell lines to potentially target oncogenes, tumor suppressor genes and cancer biomarkers. A group of the altered miRNAs were identified by miRNA target prediction tools for regulation of the INK4/CDKN2 family tumor suppressor genes. miRNA-141 was experimentally validated for INK4A 3-UTR target binding in the CMT cell lines providing an essential mechanism for the post-transcriptional regulation of the INK4A tumor suppressor gene in CMT models. A well-recognized group of miRNAs including miR-21, miR-155, miR-9, miR-34a, miR-143/145, and miR-31 were found to be altered in both CMTs and human breast cancer. These altered miRNAs might serve as potential targets for advancing the development of future therapeutic reagents. These findings further strengthen the validity and use of canine breast cancers as appropriate models for the study of human breast cancers. J. Cell. Biochem. 116: 2956-2969, 2015. (c) 2015 Wiley Periodicals, Inc.
机译:相对于正常细胞的microRNA(miRNA)表达谱分析可能揭示了与人类和动物癌症模型中基因表达改变相关的特征性调控特征。在这项研究中,评估了自发犬乳腺肿瘤(CMT)模型中来自犬基因组的277种高度表征的miRNA的综合表达谱,该模型具有一组INK4 / CDKN2家族(包括p16)的细胞周期调控和有效肿瘤抑制基因中的缺陷/ INK4A,p14ARF和p15 / INK4B。在三种CMT细胞系中鉴定出大量差异表达的miRNA,它们可能靶向癌基因,抑癌基因和癌症生物标志物。通过miRNA靶标预测工具鉴定了一组改变的miRNA,以调节INK4 / CDKN2家族肿瘤抑制基因。 miRNA-141在CMT细胞系中针对INK4A 3-UTR靶标结合进行了实验验证,为CMT模型中INK4A抑癌基因的转录后调控提供了必要的机制。已发现一组公认的miRNA,包括miR-21,miR-155,miR-9,miR-34a,miR-143 / 145和miR-31,在CMT和人乳腺癌中均发生了改变。这些改变的miRNA可能作为促进未来治疗试剂发展的潜在靶标。这些发现进一步增强了犬乳腺癌作为人类乳腺癌研究的适当模型的有效性和应用。 J.细胞。生化。 116:2956-2969,2015。(c)2015 Wiley Periodicals,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号